Your browser doesn't support javascript.
loading
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis.
Reiter, Andreas; Gotlib, Jason; Álvarez-Twose, Iván; Radia, Deepti H; Lübke, Johannes; Bobbili, Priyanka J; Wang, Aolin; Norregaard, Chelsea; Dimitrijevic, Sasa; Sullivan, Erin; Louie-Gao, Melinda; Schwaab, Juliana; Galinsky, Ilene A; Perkins, Cecelia; Sperr, Wolfgang R; Sriskandarajah, Priya; Chin, Andi; Sendhil, Selvam R; Duh, Mei Sheng; Valent, Peter; DeAngelo, Daniel J.
Afiliación
  • Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany. andreas.reiter@medma.uni-heidelberg.de.
  • Gotlib J; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA.
  • Álvarez-Twose I; Institute of Mastocytosis Studies of Castilla La Mancha (CLMast)-Spanish Reference Center (CSUR) for Mastocytosis and CIBERONC, Virgen del Valle Hospital, Toledo, Spain.
  • Radia DH; Guy's and St Thomas' NHS Foundation Trust of Guy's Hospital, London, UK.
  • Lübke J; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Bobbili PJ; Analysis Group, Inc., Boston, MA, USA.
  • Wang A; Analysis Group, Inc., Boston, MA, USA.
  • Norregaard C; Blueprint Medicines Corporation, Cambridge, MA, USA.
  • Dimitrijevic S; Blueprint Medicines Corporation, Zug, Switzerland.
  • Sullivan E; Blueprint Medicines Corporation, Cambridge, MA, USA.
  • Louie-Gao M; Blueprint Medicines Corporation, Cambridge, MA, USA.
  • Schwaab J; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Galinsky IA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Perkins C; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA.
  • Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Sriskandarajah P; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Chin A; Guy's and St Thomas' NHS Foundation Trust of Guy's Hospital, London, UK.
  • Sendhil SR; Analysis Group, Inc., Boston, MA, USA.
  • Duh MS; Analysis Group, Inc., Boston, MA, USA.
  • Valent P; Analysis Group, Inc., Boston, MA, USA.
  • DeAngelo DJ; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
Leukemia ; 36(8): 2108-2120, 2022 08.
Article en En | MEDLINE | ID: mdl-35790816
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mastocitosis Sistémica Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mastocitosis Sistémica Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania